Concepedia
1
Publications
11
Citations
H-Index
2024
Active since
Affiliations
China Pharmaceutical University(Current)
Bo Ding is an author at China Pharmaceutical University.
Publications per year
2024–2024
SGLT2 inhibitor Dapagliflozin alleviates cardiac dysfunction and fibrosis after myocardial infarction by activating PXR and promoting angiogenesis
Min Wang, Xiameng Liu, Bo Ding et al. · Biomedicine & Pharmacotherapy · 2024 · 11 citations · Full text
Rows per page
1–1 of 1